drugset / Trial / NCT02158442

Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients

NCT02158442

Phase 2 Completed 15 enrolled Osprey Medical, Inc
RandomizedParallel-groupOpen-labelTreatment

Summary

The use of the Percutaneous Isolated Limb Procedure (PILP) which enables the use of existing antibiotic therapies in a more targeted and concentrated fashion in patients with diabetes who have a significant lower limb infection and it is deemed that IV antibiotics are needed in order to salvage the limb or life.

Timeline

Start
2013-10
Primary completion
2015-02
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified Intravenous